HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 21 filers reported holding HEPION PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $10,000 | -78.3% | 8,000 | -73.6% | 0.00% | -100.0% |
| Q3 2021 | $46,000 | -23.3% | 30,300 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $60,000 | +3.4% | 30,300 | -3.2% | 0.00% | 0.0% |
| Q1 2021 | $58,000 | -32.6% | 31,300 | -20.4% | 0.00% | -50.0% |
| Q4 2020 | $86,000 | -11.3% | 39,300 | +16.3% | 0.01% | -33.3% |
| Q2 2020 | $97,000 | +56.5% | 33,800 | -2.9% | 0.01% | +28.6% |
| Q1 2020 | $62,000 | -11.4% | 34,800 | +165.4% | 0.01% | +40.0% |
| Q4 2019 | $70,000 | – | 13,113 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 582,137 | $751,000 | 0.10% |
| McAdam, LLC | 62,169 | $80,000 | 0.01% |
| JGP Wealth Management, LLC | 15,000 | $17,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 55,599 | $72,000 | 0.00% |
| Amplius Wealth Advisors, LLC | 10,000 | $12,000 | 0.00% |
| Capital Advisors, Ltd. LLC | 1 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 1,845 | $2,000 | 0.00% |
| IFP Advisors, Inc | 1 | $1,000 | 0.00% |
| CITIGROUP INC | 4,000 | $5,000 | 0.00% |